Y-Intercept (HK)’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.35M Buy
27,113
+23,039
+566% +$7.15M 0.18% 107
2026
Q2
$1.14M Buy
+4,074
New +$1.07M 0.02% 994
2026
Q1
– Sell
-22,506
Closed -$5.65M – 1844
2025
Q4
$5.65M Buy
+22,506
New +$5.98M 0.13% 193
2025
Q2
– Sell
-3,021
Closed -$703K – 1855
2025
Q1
$703K Buy
+3,021
New +$733K 0.05% 551
2024
Q4
– Sell
-4,711
Closed -$1.05M – 1448
2024
Q3
$1.05M Buy
+4,711
New +$1.04M 0.06% 431
2024
Q2
– Sell
-1,688
Closed -$369K – 1674
2024
Q1
$369K Sell
1,688
-3,562
-68% -$785K 0.03% 862
2023
Q4
$1.19M Buy
+5,250
New +$1.1M 0.11% 260
2022
Q4
– Sell
-23,145
Closed -$4.07M – 1193
2022
Q3
$4.07M Buy
+23,145
New +$4.74M 0.41% 31
2021
Q4
– Sell
-2,513
Closed -$608K – 743
2021
Q3
$608K Buy
+2,513
New +$633K 0.11% 287

Other funds holding LH

Y-Intercept (HK)'s LH Position: Q3 2026 in Review

Y-Intercept (HK) increased its Labcorp (LH) stake by 566% in Q3 2026, buying an estimated $7.15M and bringing the position to 27,113 shares worth $8.35M. The position accounts for 0.18% of the portfolio, ranked #107.

Y-Intercept (HK) first reported a position in LH in Q3 2021 and has held it in 9 quarters since. 549 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Y-Intercept (HK) held 27,113 shares of Labcorp worth $8.35M as of Q3 2026.
  • Y-Intercept (HK) bought 23,039 Labcorp shares in Q3 2026, an estimated $7.15M.
  • Labcorp made up 0.18% of Y-Intercept (HK)'s portfolio in Q3 2026, its #107 holding.
  • Y-Intercept (HK) first reported a position in Labcorp in Q3 2021 and has held it in 9 quarters since.
  • 549 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.